HIV and AIDS Trial, Recruiting NCT07293559 Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT07293559
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has several different groups of participants. People who meet the criteria for one of the following groups may be considered:

Group 1 – Pregnant or postpartum women living with HIV (Core Activity 1):

  • People who are old enough and legally able to give their own consent to participate
  • People who fall into one of these situations: currently pregnant (between 28 and 37 weeks along) and thinking about breastfeeding; currently pregnant (between 28 and 37 weeks along) and not planning to breastfeed; gave birth to a live baby after 28 February 2023, are more than 4 weeks postpartum, and did not breastfeed and do not plan to; gave birth to a live baby after 28 February 2023, are more than 4 weeks postpartum, breastfed for less than four weeks, and have stopped; or gave birth to a live baby after 28 February 2023, are more than 4 weeks postpartum, and breastfed for four weeks or longer
  • People who were diagnosed with HIV before or during their pregnancy
  • People whose main language is not English and who are willing to take part in interviews with the help of an available translator

Group 2 – Healthcare providers and related professionals (Core Activity 1):

  • People who are old enough and legally able to give their own consent to participate
  • Healthcare providers who identify as an obstetrician, midwife, nurse, infectious disease specialist (adult or paediatric), or advanced practice provider, and who were involved in the care of at least five pregnant or postpartum women with HIV and/or their babies in the three years before joining the trial
  • Professionals in supporting roles — such as social workers, lactation support providers, patient navigators, pharmacists, or doulas — who were involved in the care of at least five pregnant or postpartum women with HIV and/or their babies in the three years before joining the trial

Group 3 – Influential individuals (Core Activity 1):

  • People who have been identified by an enrolled pregnant or postpartum woman with HIV as someone who knows about her HIV status and has played a role in her infant feeding decisions
  • People who are old enough and legally able to give their own consent to participate
  • People whose main language is not English and who are willing to take part in interviews with the help of an available translator

Group 4 – Pregnant or postpartum women with HIV and their baby (Core Activity 2):

  • People who are old enough and legally able to give their own consent to participate
  • People who are pregnant with a single baby at 28 weeks or more, or who gave birth to a single live baby up to 7 days before joining the trial
  • People who were diagnosed with HIV before or during their pregnancy
  • People who are expected to be available for the full follow-up period of the study

Group 5 – Breastfeeding postpartum women with HIV and their baby (Core Activity 3):

  • People who are old enough and legally able to give their own consent to participate
  • People who are up to 7 days postpartum with a live-born baby
  • People who were diagnosed with HIV before or during their pregnancy
  • People who breastfed their baby for any length of time

Group 6 – Pilot registry testers (Core Activity 3):

  • People who are old enough and legally able to give their own consent to participate
  • People who work at a healthcare facility that provides care for women with HIV who are breastfeeding and/or their babies

Who may not be able to join:

  • People who have any condition identified during the screening period that, in the opinion of the trial site investigator, would prevent them from giving informed consent, make participation unsafe, make study results harder to interpret, or otherwise interfere with the goals of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lisa Abuogi, University of Colorado, Denver

Phone: 202-884-8480

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Registry
ClinicalTrials.gov
Start date
24 February 2026
Est. completion
24 April 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

CA 1: Factors influencing infant feeding decision; CA 1: Infants born to women with HIV who receive any breast milk; CA 2: Infant feeding method chosen; CA 2: Breastfeeding initiation among those who intended to breastfeed; CA 2: Duration of breastfeeding among PPWH who breastfeed; CA 2: Completion of intended duration of breastfeeding; CA 2: Mixed method analysis of infant feeding practices from in-depth interviews and survey data; CA 2: Breast milk samples with detectable HIV DNA or RNA; CA 2: Viral load measured in different breast milk compartments; CA 3: Data completed in registry; CA 3:...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov